Arterial smooth muscle cell PKD2 (TRPP1) channels regulate systemic blood pressure.
Simon BulleyCarlos Fernandez-PenaRaquibul HasanM Dennis LeoPadmapriya MuralidharanCharles E MackayKirk W EvansonLuiz Moreira-JuniorAlejandro Mata-DaboinSarah K BurrisQian WangKorah P KuruvillaJonathan H JaggarPublished in: eLife (2018)
Systemic blood pressure is determined, in part, by arterial smooth muscle cells (myocytes). Several Transient Receptor Potential (TRP) channels are proposed to be expressed in arterial myocytes, but it is unclear if these proteins control physiological blood pressure and contribute to hypertension in vivo. We generated the first inducible, smooth muscle-specific knockout mice for a TRP channel, namely for PKD2 (TRPP1), to investigate arterial myocyte and blood pressure regulation by this protein. Using this model, we show that intravascular pressure and α1-adrenoceptors activate PKD2 channels in arterial myocytes of different systemic organs. PKD2 channel activation in arterial myocytes leads to an inward Na+ current, membrane depolarization and vasoconstriction. Inducible, smooth muscle cell-specific PKD2 knockout lowers both physiological blood pressure and hypertension and prevents pathological arterial remodeling during hypertension. Thus, arterial myocyte PKD2 controls systemic blood pressure and targeting this TRP channel reduces high blood pressure.
Keyphrases
- blood pressure
- smooth muscle
- hypertensive patients
- heart rate
- polycystic kidney disease
- type diabetes
- stem cells
- risk assessment
- coronary artery
- mouse model
- metabolic syndrome
- cell therapy
- insulin resistance
- cancer therapy
- skeletal muscle
- mesenchymal stem cells
- climate change
- drug induced
- blood brain barrier
- cerebral ischemia